| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
|
Van Damme, Pierre
|
|
2016
|
34 |
35 |
p. 4205-4212
8 p.
|
artikel
|
| 2 |
A review of testing used in seroprevalence studies on measles and rubella
|
Dimech, Wayne
|
|
2016
|
34 |
35 |
p. 4119-4122
4 p.
|
artikel
|
| 3 |
A 16-year review of seroprevalence studies on measles and rubella
|
Dimech, Wayne
|
|
2016
|
34 |
35 |
p. 4110-4118
9 p.
|
artikel
|
| 4 |
Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia
|
Ritz, Nicole
|
|
2016
|
34 |
35 |
p. 4132-4139
8 p.
|
artikel
|
| 5 |
Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children
|
Hankin-Wei, Abigail
|
|
2016
|
34 |
35 |
p. 4243-4249
7 p.
|
artikel
|
| 6 |
Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
|
Griffiths, Ulla Kou
|
|
2016
|
34 |
35 |
p. 4213-4220
8 p.
|
artikel
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
2016
|
34 |
35 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Effects of serostatus and gender on the HRV-16-induced local immune response
|
Koch, Rebecca M.
|
|
2016
|
34 |
35 |
p. 4087-4091
5 p.
|
artikel
|
| 9 |
Efficacy of various Marek’s disease vaccines protocols for prevention of Marek’s disease virus-induced immunosuppression
|
Faiz, Nik M.
|
|
2016
|
34 |
35 |
p. 4180-4187
8 p.
|
artikel
|
| 10 |
Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
|
van den Dobbelsteen, Germie P.J.M.
|
|
2016
|
34 |
35 |
p. 4152-4160
9 p.
|
artikel
|
| 11 |
Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials
|
Moa, Aye M.
|
|
2016
|
34 |
35 |
p. 4092-4102
11 p.
|
artikel
|
| 12 |
Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification
|
Zhang, Lan
|
|
2016
|
34 |
35 |
p. 4250-4256
7 p.
|
artikel
|
| 13 |
Monitoring vaccination coverage: Defining the role of surveys
|
Cutts, Felicity T.
|
|
2016
|
34 |
35 |
p. 4103-4109
7 p.
|
artikel
|
| 14 |
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection
|
Gouma, Sigrid
|
|
2016
|
34 |
35 |
p. 4166-4171
6 p.
|
artikel
|
| 15 |
PLGA-microencapsulation protects Salmonella typhi outer membrane proteins from acidic degradation and increases their mucosal immunogenicity
|
Carreño, Juan Manuel
|
|
2016
|
34 |
35 |
p. 4263-4269
7 p.
|
artikel
|
| 16 |
Preclinical studies on new proteins as carrier for glycoconjugate vaccines
|
Tontini, M.
|
|
2016
|
34 |
35 |
p. 4235-4242
8 p.
|
artikel
|
| 17 |
Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador
|
Duque, Hernando
|
|
2016
|
34 |
35 |
p. 4140-4144
5 p.
|
artikel
|
| 18 |
Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males
|
Scherr, C.L.
|
|
2016
|
34 |
35 |
p. 4229-4234
6 p.
|
artikel
|
| 19 |
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice
|
Paes, Wayne
|
|
2016
|
34 |
35 |
p. 4123-4131
9 p.
|
artikel
|
| 20 |
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers
|
Hansen, John
|
|
2016
|
34 |
35 |
p. 4172-4179
8 p.
|
artikel
|
| 21 |
Temperature-mediated recombinant anthrax protective antigen aggregate development: Implications for toxin formation and immunogenicity
|
Amador-Molina, Juan C.
|
|
2016
|
34 |
35 |
p. 4188-4195
8 p.
|
artikel
|
| 22 |
The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique
|
Haidari, Leila A.
|
|
2016
|
34 |
35 |
p. 4161-4165
5 p.
|
artikel
|
| 23 |
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children
|
Voysey, Merryn
|
|
2016
|
34 |
35 |
p. 4221-4228
8 p.
|
artikel
|
| 24 |
Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria–Pertussis–Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) – Immunological curiosity or canary in the mine?
|
Holt, Patrick G.
|
|
2016
|
34 |
35 |
p. 4257-4262
6 p.
|
artikel
|
| 25 |
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
|
Miura, Kazutoyo
|
|
2016
|
34 |
35 |
p. 4145-4151
7 p.
|
artikel
|
| 26 |
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges
|
Yan, Qin
|
|
2016
|
34 |
35 |
p. 4196-4204
9 p.
|
artikel
|
Tijdschrift beschrijving